Effects of storage time on Cytomegalovirus DNA stability in plasma determined by quantitative real-time PCR

Journal of Virological Methods

Volumn 207, Issue , 2014, Pages 196-199

  Xie, Li ^a   Liang, Xiao Nan ^a   Deng, Yan ^a   Wang, Jian ^a   He, Yu ^a   Li, Tai Jie ^a   Huang, Shan ^a   Qin, Xue ^a   Li, Shan ^a  

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Cytomegalovirus; EDTA plasma; Stability; Storage time

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MALE; MEASUREMENT ACCURACY; NONHUMAN; ORGAN TRANSPLANTATION; PLASMA; PRIORITY JOURNAL; QUANTITATIVE REAL TIME POLYMERASE CHAIN REACTION; REAL TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY; STORAGE; STORAGE TEMPERATURE; STORAGE TIME; VIRUS LOAD; ADOLESCENT; CYTOMEGALOVIRUS INFECTIONS; GENETICS; GRAFT RECIPIENT; ISOLATION AND PURIFICATION; LABORATORY DIAGNOSIS; MIDDLE AGED; PRESCHOOL CHILD; PROCEDURES; TEMPERATURE; TIME; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PLASMA; REAL-TIME POLYMERASE CHAIN REACTION; SPECIMEN HANDLING; TEMPERATURE; TIME FACTORS; TRANSPLANT RECIPIENTS; VIRAL LOAD; YOUNG ADULT;

EID: 84905215823     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2014.05.024     Document Type: Article

References (13)

1. Abdul-Ali D., Kraft C.S., Ingersoll J., Frempong M., Caliendo A.M. Cytomegalovirus DNA stability in EDTA anti-coagulated whole blood and plasma samples. J. Clin. Virol. 2011, 52:222-224.
2. Baleriola C., Johal H., Jacka B., Chaverot S., Bowden S., Lacey S., Rawlinson W. Stability of hepatitis C virus, HIV, and hepatitis B virus nucleic acids in plasma samples after long-term storage at -20°C and -70°C. J. Clin. Microbiol. 2011, 49:3163-3167.
3. Boivin G., Handfield J., Toma E., Murray G., Lalonde R., Tevere V.J. Evaluation of the AMPLICOR cytomegalovirus test with specimens from human immunodeficiency virus-infected subjects. J. Clin. Microbiol. 1998, 36:2509-2513.
4. Boom R., Sol C.J., Schuurman T., Van Breda A., Weel J.F., Beld M., Ten Berge I.J., Wertheim-Van Dillen P.M., De Jong M.D. Human cytomegalovirus DNA in plasma and serum specimens of renal transplant recipients is highly fragmented. J. Clin. Microbiol. 2002, 40:4105-4113.
5. Farkas D.H., Drevon A.M., Kiechle F.L., Dicarlo R.G., Heath E.M., Crisan D. Specimen stability of DNA-based diagnostic testing. Diagn. Mol. Pathol. 1996, 5:227-235.
6. Gerna G., Lilleri D., Caldera D., Furione M., Zenone-Bragotti L., Alessandrino E.P. Validation of a DNAemia cutoff for preemptive therapy of cytomegalovirus in adult hematopoietic stem cell transplant recipients. Bone Marrow Transplant. 2008, 41:873-879.
7. Gimeno C., Solano C., Latorre J.C., Hernández-Boluda J.C., Clari M.A., Remigia M.J., Furió S., Calabuig M., Tormo N., Navarro D. Quantification of DNA in plasma by an automated real-time PCR assay (cytomegalovirus PCR kit) for surveillance of active cytomegalovirus infection and guidance of preemptive therapy for allogeneic hematopoietic stem cell transplant recipients. J. Clin. Microbiol. 2008, 46:3311-3318.
8. Harrington S.M., Buller R.S., Storch G.A., Li L., Fisher S.H., Murray P.R., Gea-Banacloche J.C. The effect of quantification standards used in real-time CMV PCR assays on guidelines for initiation of therapy in allogeneic stem cell transplant patients. Bone Marrow Transplant. 2007, 39:237-238.
9. Ljungman P. CMV: a warrior against leukemia?. Blood 2013, 122:1101-1102.
10. Nesbitt S.E., Cook L., Jerome K.R. Cytomegalovirus quantitation by real-time PCR is unaffected by delayed separation of plasma from whole blood. J. Clin. Microbiol. 2004, 42:1296-1297.
11. Schafer P., Tenschert W., Schroter M., Gutensohn K., Laufs R. False-positive results of plasma PCR for cytomegalovirus DNA due to delayed sample preparation. J. Clin. Microbiol. 2000, 38:3249-3253.
12. Verkruyse L.A., Storch G.A., Devine S.M., DiPersio J.F., Vij R. Once daily ganciclovir as initial pre-emptive therapy delayed until threshold CMV load > or =10000 copies/ml: a safe and effective strategy for allogeneic stem cell transplant patients. Bone Marrow Transplant. 2006, 37:51-56.
13. Yun Z., Lewensohn-Fuchs I., Ljungman P., Ringholm L., Jonsson J., Albert J. A real-time TaqMan PCR for routine quantitation of cytomegalovirus DNA in crude leukocyte lysates from stem cell transplant patients. J. Virol. Methods 2003, 110:73-79.